Mahmud R. Elbackush, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7964 Arden Ct, Dunn Loring, VA 22027 Phone: 703-573-8971 Fax: 703-573-8971 |
News Archive
Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The Company's lead product, JVS-100, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.
"Scientists have found a way to track minutely-differing strains of the 'superbug' MRSA [methicillin-resistant Staphylococcus aureus] as they spread between people and across the globe, a finding that could aid efforts to control the deadly bacteria," Reuters/ABC News reports (Kelland, 1/21).
Claims are reportedly being made that higher than average cancer deaths in Innisfail, in north Queensland are due to the secret testing of Agent Orange there in 1960s.
GenoMed has filed a patent application on two additional genes linked to common cancers. These genes are the third and fourth identified as a result of GenoMed's research in 2005 to date. They have the potential to improve the outcomes for those individuals afflicted with these cancers.
› Verified 5 days ago